Preoperative preparation of patients with advanced liver disease
- PMID: 15064669
- DOI: 10.1097/01.ccm.0000115624.13479.e6
Preoperative preparation of patients with advanced liver disease
Abstract
Objective: To review the characteristic features of patients with advanced liver disease that may lead to increased perioperative morbidity and mortality rates.
Design: Literature review.
Results: Patients with end-stage liver disease are at high risk of major complications and death following surgery. The most common complications are secondary to acute liver failure and include severe coagulopathy, encephalopathy, adult respiratory distress syndrome, acute renal failure, and sepsis. The degree of malnutrition, control of ascites, level of encephalopathy, prothrombin time, concentration of serum albumin, and concentration of serum bilirubin predict the risk of complications and death following surgery. Other determinants of adverse outcome include emergency surgery, advanced age, and cardiovascular disease. Portal hypertension is a prominent feature of advanced liver disease, and it predisposes the patient to variceal hemorrhage, hepatorenal syndrome, hepatopulmonary syndrome, and uncontrolled ascites. Portal hypertension can be ameliorated by percutaneous or surgical portasystemic shunting procedures. If well-defined contraindications are not present, patients with advanced liver disease should be evaluated for orthotopic liver transplantation from a cadaver donor or possible living-related liver transplantation.
Conclusions: Optimal preparation, which addresses the common features of advanced liver disease, may decrease the risk of complications or death following surgery. Preparation should include correcting coagulopathy, minimizing preexisting encephalopathy, preventing sepsis, and optimizing renal function.
Comment in
-
Portopulmonary hypertension and hepatopulmonary syndrome: two different entities affecting pulmonary vasculature in liver disease.Crit Care Med. 2005 Jan;33(1):269. doi: 10.1097/01.ccm.0000151051.73799.a1. Crit Care Med. 2005. PMID: 15644703 No abstract available.
-
Hepatopulmonary syndrome and portopulmonary hypertension.Crit Care Med. 2005 Feb;33(2):470-1; author reply 471. doi: 10.1097/01.ccm.0000153598.84976.e9. Crit Care Med. 2005. PMID: 15699878 No abstract available.
-
The distinct concepts and implications of hepatopulmonary syndrome and portopulmonary hypertension.Crit Care Med. 2005 Feb;33(2):470. doi: 10.1097/01.ccm.0000153595.76419.f3. Crit Care Med. 2005. PMID: 15699879 No abstract available.
Similar articles
-
Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.Hepatogastroenterology. 2003 Nov-Dec;50(54):1753-5. Hepatogastroenterology. 2003. PMID: 14696397
-
New management options for end-stage chronic liver disease and acute liver failure: potential for pediatric patients.Paediatr Drugs. 2006;8(1):1-13. doi: 10.2165/00148581-200608010-00001. Paediatr Drugs. 2006. PMID: 16494508 Review.
-
Acute respiratory failure complicating advanced liver disease.Semin Respir Crit Care Med. 2012 Feb;33(1):96-110. doi: 10.1055/s-0032-1301738. Epub 2012 Mar 23. Semin Respir Crit Care Med. 2012. PMID: 22447264 Review.
-
Major adverse events, pretransplant assessment and outcome prediction.J Gastroenterol Hepatol. 2009 Nov;24(11):1716-24. doi: 10.1111/j.1440-1746.2009.06025.x. J Gastroenterol Hepatol. 2009. PMID: 20136958 Review.
-
[Standardization of intensive therapy tactics for acute hepatic insufficiency in patients with liver cirrhosis after portosystem shunting].Khirurgiia (Mosk). 2018;(8):61-67. doi: 10.17116/hirurgia2018861. Khirurgiia (Mosk). 2018. PMID: 30113595 Russian.
Cited by
-
Systemic hemodynamics in advanced cirrhosis: Concerns during perioperative period of liver transplantation.World J Hepatol. 2016 Sep 8;8(25):1047-60. doi: 10.4254/wjh.v8.i25.1047. World J Hepatol. 2016. PMID: 27660671 Free PMC article. Review.
-
Preoperative transjugular intrahepatic portosystemic shunt (TIPS) for cirrhotic patients undergoing abdominal and pelvic surgeries.Surg Endosc. 2009 Jul;23(7):1594-8. doi: 10.1007/s00464-009-0405-7. Epub 2009 Mar 5. Surg Endosc. 2009. PMID: 19263108
-
Impaired albumin function: a novel potential indicator for liver function damage?Ann Med. 2019 Nov-Dec;51(7-8):333-344. doi: 10.1080/07853890.2019.1693056. Epub 2019 Nov 21. Ann Med. 2019. PMID: 31714153 Free PMC article. Review.
-
Gallstones in chronic liver disease.J Gastrointest Surg. 2005 May-Jun;9(5):739-46. doi: 10.1016/j.gassur.2004.09.041. J Gastrointest Surg. 2005. PMID: 15862273 Review.
-
Impact of cirrhosis on surgical outcome after pancreaticoduodenectomy.World J Gastroenterol. 2013 Nov 7;19(41):7129-37. doi: 10.3748/wjg.v19.i41.7129. World J Gastroenterol. 2013. PMID: 24222957 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical